High-content screening in infectious diseases.

The last decade has seen the development of automated microscopy and its adaptation for various areas of research, particularly infectious disease. Most of the high-content screening (HCS) platforms now integrate all of the following necessary steps: automated pipettes for assay miniaturization in 384-well plates, automated image acquisition and data storage and analysis. HCS was initially associated with RNA interference genetic screens for identifying host factors involved in host-pathogen interactions. More recently, both in academia and in industry, HCS has been adapted for drug discovery purposes. High-content analysis enables intracellular tracking of viral particles to profile the antiviral mechanisms of each compound. Adaptation to high-throughput screening in bacteriology and parasitology has already led to the discovery of new types of host-specific inhibitors that differ from those inhibitors that act directly on microbes.

[1]  K. Yeow,et al.  Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.

[2]  M. Garcia-Blanco,et al.  Factors Affecting Reproducibility between Genome-Scale siRNA-Based Screens , 2010, Journal of biomolecular screening.

[3]  G. Ruthel,et al.  Development of High-Content Imaging Assays for Lethal Viral Pathogens , 2010, Journal of biomolecular screening.

[4]  Oliver Rausch,et al.  High content cellular screening. , 2006, Current opinion in chemical biology.

[5]  Norbert Perrimon,et al.  Genome-Wide RNAi Screen for Host Factors Required for Intracellular Bacterial Infection , 2005, Science.

[6]  E. Krausz,et al.  Cell-based high-content screening of small-molecule libraries. , 2007, Current opinion in chemical biology.

[7]  H. Agaisse,et al.  RNAi Screen in Drosophila Cells Reveals the Involvement of the Tom Complex in Chlamydia Infection , 2007, PLoS pathogens.

[8]  Auguste Genovesio,et al.  IM.Grid, a Grid computing approach for Image Mining of High Throughput-High Content Screening , 2008, 2008 9th IEEE/ACM International Conference on Grid Computing.

[9]  Y. Kalaidzidis,et al.  Systems survey of endocytosis by multiparametric image analysis , 2010, Nature.

[10]  J. Cechetto,et al.  High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. , 2010, Future medicinal chemistry.

[11]  C. Locht,et al.  Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. , 2011, Journal of medicinal chemistry.

[12]  E. Holland,et al.  Validation of a high-content screening assay using whole-well imaging of transformed phenotypes. , 2011, Assay and drug development technologies.

[13]  Jacques Neefjes,et al.  Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 , 2007, Nature.

[14]  Ruth R. Montgomery,et al.  RNA interference screen for human genes associated with West Nile virus infection , 2008, Nature.

[15]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[16]  Anang A. Shelat,et al.  Chemical genetics of Plasmodium falciparum , 2010, Nature.

[17]  D. A. Stein,et al.  High-content assay to identify inhibitors of dengue virus infection. , 2010, Assay and drug development technologies.

[18]  Kate E. Jones,et al.  Global trends in emerging infectious diseases , 2008, Nature.

[19]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[20]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[21]  Stewart T. Cole,et al.  High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors , 2009, PLoS pathogens.

[22]  Jan de Sonneville,et al.  A High-Throughput Screen for Tuberculosis Progression , 2011, PloS one.

[23]  E. Chatelain,et al.  Drug discovery and development for neglected diseases: the DNDi model , 2011, Drug design, development and therapy.

[24]  N. Heaton,et al.  RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis , 2009, PLoS pathogens.

[25]  S. Butler,et al.  Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors. , 2005, Antiviral research.

[26]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[27]  D Fenistein,et al.  A fast, fully automated cell segmentation algorithm for high‐throughput and high‐content screening , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[28]  Wolfgang Link,et al.  High content screening: seeing is believing. , 2010, Trends in biotechnology.

[29]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[30]  Daniel Becker,et al.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication , 2010, Nature.

[31]  F. Pauwels,et al.  Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex. , 2010, Journal of virological methods.

[32]  Auguste Genovesio,et al.  Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds , 2010, PLoS neglected tropical diseases.

[33]  S. Bozzaro,et al.  The Professional Phagocyte Dictyostelium discoideum as a Model Host for Bacterial Pathogens , 2011, Current drug targets.

[34]  Roger G. Linington,et al.  An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. , 2011, Molecular bioSystems.

[35]  Norbert Perrimon,et al.  Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection , 2005, Science.

[36]  Marc Bickle,et al.  The beautiful cell: high-content screening in drug discovery , 2010, Analytical and bioanalytical chemistry.

[37]  Qisheng Li,et al.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation , 2009, Proceedings of the National Academy of Sciences.

[38]  A. Fauci,et al.  The challenge of emerging and re-emerging infectious diseases , 2004, Nature.